Esther Martinborough
Director/Board Member at CODEXIS, INC.
Net worth: 153 522 $ as of 2024-04-29
Esther Martinborough active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CODEXIS, INC. | Director/Board Member | 2021-02-01 | - |
| Independent Dir/Board Member | 2021-02-01 | - | |
Escient Pharmaceuticals, Inc.
 Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 2023-03-31 | - |
| Corporate Officer/Principal | 2018-07-31 | 2023-03-31 |
Career history of Esther Martinborough
Former positions of Esther Martinborough
| Companies | Position | Start | End |
|---|---|---|---|
| RECEPTOS INC | Director/Board Member | 2007-12-31 | 2014-12-31 |
| Corporate Officer/Principal | 2007-12-31 | 2017-12-31 |
Training of Esther Martinborough
| Swiss Federal Institute of Technology | Doctorate Degree |
| University of California | Graduate Degree |
Statistics
International
| United States | 5 |
| Switzerland | 2 |
Operational
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Independent Dir/Board Member | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Process Industries | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CODEXIS, INC. | Process Industries |
| Private companies | 2 |
|---|---|
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | Health Technology |
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Receptos LLC engages in the provision of developing and commercializing of therapeutic candidates for the treatment of immune and inflammatory diseases. It offers Ozanimod for relapsing multiple sclerosis, Ozanimod for inflammatory bowel disease and RPC4046 for eosinophilic esophagitis. The company was founded by Marcus F. Boehm, Robert J. Peach, William H. Rastetter, Hugh Rosen and Raymond C. Stevens on September 26, 2008 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Esther Martinborough
- Experience
